DENVER, Colo. (247marketnews.com) -- The market is watching a diverse group of companies as catalysts converge. NeOnc Technologies Holdings (NASDAQ:NTHI) attracted fresh Wall Street coverage around its brain-cancer pipeline; Profusa (NASDAQ:PFSA) is moving closer to a potential European regulatory milestone; Sky Quarry (NASDAQ:SKYQ) restarted Nevada's Eagle Springs Refinery; Glucotrack (NASDAQ:GCTK) is turning its Lōkahi asset-discovery platform toward external revenue; while Greenland Mines Ltd. (NASDAQ:GRML) and Greenland Energy Company (NASDAQ:GLND) are advancing separate projects in Greenland.
NeOnc: $20 Wall Street Target Puts Clinical Catalysts in Focus
NeOnc (NASDAQ:NTHI) is heading into a potentially important stretch for its experimental brain-cancer programs after Roth Capital initiated coverage with a Buy rating and a $20 price target. The firm's research centers on NEO100 and NEO212, with potential development milestones extending into 2026 and projected commercial launches further out. The $20 target is an analyst forecast, not a future performance guarantee.
The clinical story has also become more tangible. In August, NeOnc reported Phase 2a results for NEO100 in recurrent IDH1-mutant high-grade glioma, including six-month progression-free survival of 48.9% versus a prespecified 20% benchmark and median overall survival of 26.09 months in the 24-patient cohort. The company said it intended to engage the FDA regarding a potential registrational pathway.
NeOnc has simultaneously been putting capital behind the pipeline. The company completed a $15 million registered direct offering in September, while management subsequently reported open-market purchases. NEO212 remains another development track, targeting recurrent glioblastoma and brain metastases.
Profusa: Lumee Moves Closer to The European Finish Line
Profusa (NASDAQ:PFSA) has delivered a potentially significant regulatory update for its Lumee Oxygen Platform after receiving a positive decision from GMED regarding certification of its quality-management system to ISO 13485. Profusa said it expects the certification to be completed in early October while continuing the remaining conformity-assessment activities required under Europe's Medical Device Regulation.
“We are pleased with the progress we have made in strengthening our quality management system,” President Ben Hwang, Ph.D., said, describing the development as “a significant milestone for Profusa.” The distinction between the current milestone and final commercialization remains important: ISO 13485 certification is part of the regulatory process, while the company still needs to complete applicable MDR conformity assessment before potential CE marking.
Lumee is designed to provide continuous, real-time monitoring of tissue oxygen levels through Profusa's tissue-integrated biosensor technology. If the remaining GMED activities are successfully completed, the company says the process could support issuance of the applicable MDR certificate and subsequent CE marking.
Sky Quarry: Nevada Refinery Restart Puts Operations Under the Microscope
Sky Quarry (NASDAQ:SKYQ) moved its Eagle Springs Refinery near Ely, Nevada, from preparation back into operations after receiving an air permit from the Nevada Division of Environmental Protection. The refinery, operated by wholly owned Foreland Refining Corporation, underwent approximately $300,000 in repairs and upgrades ahead of the restart.
Eagle Springs has a stated nameplate capacity of approximately 5,000 barrels of crude oil per day, while Sky Quarry says it currently has approximately 15,000 barrels of crude oil inventory on hand and expects additional supply as operations progress, making the company's next operational updates particularly important as investors look for evidence of a sustained ramp.
“Receiving this permit and restarting Nevada's only crude oil refinery is a major step for Sky Quarry,” Interim CEO Marcus Laun said. The company is also continuing work around its PR Spring opportunity in Utah and potential use of its 7-megawatt power-generation capacity.
Glucotrack: Lōkahi Turns Internal Asset Engine into Potential Revenue
Glucotrack (NASDAQ:GCTK) is developing a second business narrative through subsidiary Lōkahi Therapeutics and its proprietary ai² PIPELINE platform. Innovate GBM, a nonprofit focused on accelerating treatments for glioblastoma and other brain tumors, has become the first external organization to engage the platform on a fee-for-service basis to identify and evaluate therapeutic assets for potential licensing and development.
The significance is the potential business-model transition. Lōkahi says ai² PIPELINE previously functioned as an internal asset-discovery engine supported by university collaborations. External sponsorship creates a pathway for the platform to generate revenue while allowing outside organizations to direct the search toward specific therapeutic opportunities.
“Innovate GBM’s engagement is the next step forward for the ai² PIPELINE,” Glucotrack CEO Erik Emerson said. Innovate GBM's Kush Thukral called the platform a “disciplined, capital-efficient way to search systematically for overlooked brain tumor assets.” Glucotrack has also continued expanding the broader ai² platform into additional business divisions, making the external engagement an important test of whether its discovery infrastructure can develop into a scalable commercial service.
Greenland Mines: $42 Million Financing Loads the War Chest For 2027
Greenland Mines (NASDAQ:GRML) has strengthened its balance sheet with more than $42 million from existing investors through a registered direct offering and exercise of previously issued warrants. The company says the capital substantially addresses its planned funding requirements through targeted 2027 milestones and has therefore terminated its ATM facility.
The financing comes alongside completion of the company's 2026 field program at the Sarfartoq NdPr Rare Earth Project in southwest Greenland. Greenland Mines conducted geological and structural mapping, drone-supported surveying and systematic rock sampling across priority areas of the Sarfartoq Carbonatite Complex. The company says samples are expected to undergo laboratory analysis, while its field camp has been winterized for potential work ahead of the 2027 season.
“Now it’s about execution,” President Dr. Bo Møller Stensgaard said. Sarfartoq's existing ST1 Mineral Resource stands at approximately 12.2 million tons grading 1.32% TREO, according to the company, while an independent Initial Assessment reported a high-case pre-tax NPV8 of approximately $2.05 billion and a pre-tax IRR of 118.6%.
Greenland Energy: Jameson Land Drilling Timeline Extends To 2028
Greenland Energy (NASDAQ:GLND) is extending the timetable for its Jameson Land Basin exploration program in East Greenland after reaching an amended agreement with 80 Mile plc. The longstop date for the first exploration well has moved from December 31, 2026, to December 31, 2028, while the second well deadline has also moved to December 31, 2028.
Under the amended arrangement, Greenland Energy has assumed its subsidiary March GL Company's rights and obligations under the existing farm-out agreement and will take sole responsibility, at its own cost, for securing and maintaining the permits and approvals required for the drilling program. The company will pay 80 Mile a £500,000 fee in connection with the amendment, while 80 Mile remains responsible for other government consents under the farm-out agreement.
“This amendment provides the additional time and a clear framework for us to continue advancing the Jameson Land program while the required permitting process progresses,” CEO Robert Price said. Greenland Energy's challenge now is execution: securing the necessary approvals, maintaining project preparations and ultimately moving toward exploration drilling. The company and 80 Mile have also previously announced indicative merger terms that would consolidate the Jameson Land licenses under Greenland Energy, adding another corporate-development element to the story.
About 24/7 Market News
In today's fast-moving markets, visibility is everything and 24/7 Market News (24/7) provides a powerful suite of investor relations and public relations solutions designed to elevate your company’s profile quickly and effectively. Whether you're an established name seeking broader awareness, or a micro-cap looking to break out of obscurity, 24/7 delivers targeted, high-impact coverage through timely news distribution, analyst report placements, featured editorials, and multi-channel amplification across financial platforms, social media, and investor communities. Our services help cut through the noise, attract institutional interest, drive exposure, and build long-term shareholder credibility, all while maintaining full SEC compliance and transparency. For Analyst Report coverage, custom IR campaigns, press release syndication, or other tailored investor and public relations solutions, contact [email protected] to discuss how 24/7 can help accelerate your company’s visibility and valuation trajectory.
24/7 is compensated by NTHI to provide ongoing news coverage of expected upcoming catalysts and events as well as market outreach services. For further disclosure information, please click here. This should not be construed as financial or investment advice. Trading involves substantial risk; consult your financial advisor.
Important Editorial Note: 247 highlights companies approaching significant catalysts and inflection points. This report reflects information available at the time of publication. Since developments can occur rapidly, readers should independently verify current information and review all company filings and disclosures.
CONTACT:
24/7 Market News
[email protected]
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company's ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Actual results could differ materially from those described in these forward-looking statements due to a number of factors, including without limitation, the Company's ability to continue as a going concern, general economic conditions, and other risk factors detailed in the Company's filings with the SEC. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update such forward-looking statements except in accordance with applicable law.